Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 28-Mar-24 4:32 PM View:  | Pyxis Oncology, Inc. (PYXS) | 26-Mar-24 | Grant | 38,741 | -- | -- | 100% 0 to 38.74K | |
| 06-Mar-23 6:46 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 02-Mar-23 | Sale (Planned) | 5,074 | $3.63 | $18,403.40 | (2%) 295.87K to 290.79K | |
| 03-Mar-23 5:15 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-23 | Grant | 141,328 | -- | -- | 91% 154.54K to 295.87K | |
| 18-Nov-22 8:13 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-22 | Sale (Planned) | 4,342 | $4.49 | $19,496.70 | (3%) 158.88K to 154.54K | |
| 18-Aug-22 6:21 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Aug-22 | Sale (Planned) | 4,124 | $5.03 | $20,760.20 | (3%) 163.01K to 158.88K | |
| 19-May-22 5:08 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-May-22 | Sale (Planned) | 3,873 | $5.32 | $20,596.60 | (2%) 166.88K to 163.01K | |
| 03-Mar-22 7:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-22 | Grant | 78,506 | -- | -- | 87% 90.59K to 169.1K | |
| 03-Mar-22 7:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-22 | Sale (Planned) | 2,221 | $9.86 | $21,890.20 | (1%) 169.1K to 166.88K | |
| 14-Feb-22 5:42 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 10-Feb-22 | Option Exercise | 5,000 | $9.58 | $47,900.00 | 6% 90.59K to 95.59K | |
| 14-Feb-22 5:42 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 10-Feb-22 | Planned Option Sale | 5,000 | $16.00 | $80,000.00 | (5%) 95.59K to 90.59K | |
| 05-Jan-22 4:47 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 03-Jan-22 | Option Exercise | 5,000 | $9.58 | $47,900.00 | 6% 90.59K to 95.59K | |
| 05-Jan-22 4:47 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 03-Jan-22 | Market Option Sale (Planned) | 5,000 | $16.01 | $80,050.00 | (5%) 95.59K to 90.59K | |
| 03-Dec-21 4:15 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Dec-21 | Option Exercise | 5,000 | $9.58 | $47,900.00 | 6% 90.59K to 95.59K | |
| 03-Dec-21 4:15 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Dec-21 | Market Option Sale (Planned) | 5,000 | $17.94 | $89,688.50 | (5%) 95.59K to 90.59K | |
| 18-Nov-21 5:52 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 16-Nov-21 | Market Sale (Planned) | 2,199 | $17.12 | $37,640.10 | (2%) 92.79K to 90.59K | (4%) |
| 04-Nov-21 4:10 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 02-Nov-21 | Option Exercise | 5,000 | $9.58 | $47,900.00 | 5% 92.79K to 97.79K | |
| 04-Nov-21 4:10 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 02-Nov-21 | Market Option Sale (Planned) | 5,000 | $16.41 | $82,050.00 | (5%) 97.79K to 92.79K | |
| 19-Aug-21 7:32 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 17-Aug-21 | Market Sale (Planned) | 2,152 | $12.53 | $26,968.90 | (2%) 94.94K to 92.79K | < 1% |
| 20-May-21 4:32 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-May-21 | Market Sale (Planned) | 5,184 | $14.55 | $75,427.20 | (5%) 100.13K to 94.94K | 4% |
| 03-Mar-21 5:17 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-21 | Grant | 53,879 | -- | -- | 116% 46.25K to 100.13K | |
| 19-May-20 7:17 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 14-May-20 | Grant | 46,250 | -- | -- | 100% 0 to 46.25K | |
| 19-Feb-20 4:23 PM View: | Gossamer Bio, Inc. (GOSS) | 14-Feb-20 | Grant | 46,500 | -- | -- | 100% 0 to 46.5K | |
| 31-Dec-19 5:00 PM View: | Gossamer Bio, Inc. (GOSS) | 30-Dec-19 | Option Exercise | 40,000 | $10.71 | $428,400.00 | 100% 0 to 40.0K | |
| 31-Dec-19 5:00 PM View: | Gossamer Bio, Inc. (GOSS) | 30-Dec-19 | Market Option Sale | 40,000 | $15.00 | $600,004.00 | (100%) 40.0K to 0 | 31% |
| 31-Dec-19 5:00 PM View: | Gossamer Bio, Inc. (GOSS) | 27-Dec-19 | Option Exercise | 1,994 | $10.71 | $21,355.70 | 100% 0 to 1.99K | |
| 31-Dec-19 5:00 PM View: | Gossamer Bio, Inc. (GOSS) | 27-Dec-19 | Market Option Sale | 1,994 | $15.81 | $31,534.10 | (100%) 1.99K to 0 | 35% |
| 11-Oct-16 9:42 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 09-Oct-16 | Grant | 12,500 | -- | -- | 57% 21.94K to 34.44K | |
| 12-Jan-16 5:38 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 11-Jan-16 | Option Exercise | 2,500 | $4.56 | $11,400.00 | 12% 20.64K to 23.14K | |
| 12-Jan-16 5:38 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 11-Jan-16 | Market Option Sale (Planned) | 2,500 | $20.01 | $50,021.00 | (11%) 23.14K to 20.64K | 96% |
| 08-Jan-16 7:27 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 07-Jan-16 | Market Sale | 1 | $21.33 | $21.33 | (< 1%) 20.64K to 20.64K | 96% |
| 08-Jan-16 7:27 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 06-Jan-16 | Market Sale | 2,161 | $22.28 | $48,139.10 | (9%) 22.8K to 20.64K | 96% |
| 14-Dec-15 5:02 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Dec-15 | Option Exercise | 2,500 | $4.56 | $11,400.00 | 11% 22.8K to 25.3K | |
| 14-Dec-15 5:02 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Dec-15 | Market Option Sale (Planned) | 2,500 | $20.49 | $51,231.20 | (10%) 25.3K to 22.8K | 96% |
| 12-Nov-15 6:48 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Nov-15 | Option Exercise | 2,500 | $4.56 | $11,400.00 | 11% 22.8K to 25.3K | |
| 12-Nov-15 6:48 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Nov-15 | Market Option Sale (Planned) | 2,500 | $21.17 | $52,923.00 | (10%) 25.3K to 22.8K | 96% |
| 27-Oct-15 7:14 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 26-Oct-15 | Option Exercise | 5,000 | $4.56 | $22,800.00 | 22% 22.8K to 27.8K | |
| 27-Oct-15 7:14 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 26-Oct-15 | Market Option Sale (Planned) | 5,000 | $20.00 | $100,000.00 | (18%) 27.8K to 22.8K | 96% |
| 12-Aug-15 7:14 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Aug-15 | Option Exercise | 2,500 | $4.56 | $11,400.00 | 11% 22.38K to 24.88K | |
| 12-Aug-15 7:14 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Aug-15 | Market Option Sale (Planned) | 2,500 | $22.25 | $55,621.50 | (10%) 24.88K to 22.38K | 96% |
| 13-Jul-15 5:28 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Jul-15 | Option Exercise | 2,500 | $4.56 | $11,400.00 | 11% 22.38K to 24.88K | |
| 13-Jul-15 5:28 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Jul-15 | Market Option Sale (Planned) | 2,500 | $20.13 | $50,325.00 | (10%) 24.88K to 22.38K | 96% |
| 07-Jul-15 5:06 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 06-Jul-15 | Option Exercise | 2,500 | $4.56 | $11,400.00 | 11% 22.38K to 24.88K | |
| 07-Jul-15 5:06 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 06-Jul-15 | Market Option Sale (Planned) | 2,500 | $21.22 | $53,050.00 | (10%) 24.88K to 22.38K | 96% |
| 14-Apr-15 3:00 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Apr-15 | Option Exercise | 1,500 | $4.56 | $6,840.00 | 7% 22.38K to 23.88K | |
| 14-Apr-15 3:00 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Apr-15 | Market Option Sale (Planned) | 1,500 | $26.51 | $39,765.00 | (6%) 23.88K to 22.38K | 97% |
| 12-Mar-15 8:00 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Mar-15 | Option Exercise | 1,500 | $4.56 | $6,840.00 | 7% 21.62K to 23.12K | |
| 12-Mar-15 8:00 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Mar-15 | Market Option Sale (Planned) | 1,500 | $27.17 | $40,753.60 | (6%) 23.12K to 21.62K | 97% |
| 12-Feb-15 5:34 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Feb-15 | Option Exercise | 1,500 | $4.56 | $6,840.00 | 7% 21.62K to 23.12K | |
| 12-Feb-15 5:34 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 10-Feb-15 | Market Option Sale (Planned) | 1,500 | $24.23 | $36,351.00 | (6%) 23.12K to 21.62K | 97% |
| 14-Jan-15 5:45 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 12-Jan-15 | Option Exercise | 1,500 | $4.56 | $6,840.00 | 7% 21.62K to 23.12K |